Gastrointestinal side effects of prescription medications in the older adult

Journal of Clinical Gastroenterology

Volumn 43, Issue 2, 2009, Pages 103-110

  Jain, Vishal ^a,b   Pitchumoni, C S ^a,c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Adverse reactions; Drug induced damage; Gastrointestinal; Older adult

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ASCORBIC ACID; BARBITURIC ACID DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; DIAZEPAM; DOXYCYCLINE; FERROUS SULFATE; GRISEOFULVIN; IRON; LITHIUM; MORPHINE; NIFEDIPINE; NITRIC ACID DERIVATIVE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENYTOIN; POTASSIUM CHLORIDE; POTASSIUM DERIVATIVE; QUINIDINE; SILDENAFIL; SULFONAMIDE; TETRACYCLINE; THEOPHYLLINE; UNINDEXED DRUG; PRESCRIPTION DRUG;

BONE MARROW SUPPRESSION; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DYSGEUSIA; DYSPEPSIA; ESOPHAGITIS; ESOPHAGUS ULCER; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; GINGIVA HYPERPLASIA; HEALTH CARE COST; HUMAN; MOUTH ULCER; NAUSEA; PANCREATITIS; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; VOMITING; XEROSTOMIA; AGED; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG TOXICITY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; INCIDENCE; PATHOLOGY;

AGED; DRUG TOXICITY; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; INCIDENCE; NONPRESCRIPTION DRUGS; PRESCRIPTION DRUGS;

EID: 64749084626     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31818f9227     Document Type: Review

References (78)

1. Lutter RW. FDA statement before House of Representative Subcommittee on Criminal Justice, Drug Policy and Human Resources on July 11, 2006. Available at: http://www.fda.gov/ ola/2006/counterfeit0711.html. Accessed April 1, 2008.
2. Knapp DE, Robinson JI, Britt AL. Annual Adverse Drug Report 1995 by the FDA. Available at: http://www.fda.gov/ cder/reports/annrep95.pdf. Accessed April 1, 2008.
3. Jorgensen T, Johansson S, Kenerfalk A, et al. Prescription drug use, diagnoses and healthcare utilization among the elderly. Ann Pharmacother. 2001;35:1004-1009. (Pubitemid 32880015)
4. Dharmarajan TS, Ugalino JT. Understanding the Pharmacology of Aging. Hospital Physician Geriatric Medicine Board Review Manual. Vol.1. Wayne, PA: Turner White Communications Inc; 2000:1-12.
5. Nola L, O'Malley K. Prescribing for the elderly. Part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988;36:142-149. (Pubitemid 18039559)
6. Dharmarajan TS, Pitchumoni CS, Shiva Kumar K. Druginduced liver disease in older adults. Pract Gastroenterol. 2001;XXV:43-60.
7. Andrade RJ, Robles M, Fernandez-Castaner A, et al. Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol. 2007;12:329-340. (Pubitemid 46178965)
8. Lucena MI, Garcia-Cortes M, Cueto R, et al. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol. 2008;22:141-158.
9. Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf. 2007;30:277-294.
10. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. Br Med J. 1997;315: 1096-1099.
11. Monane M, Avron J, Beers MH, et al. Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med. 1993;153:633-638. (Pubitemid 23072392)
12. Abdollahi M, Radfar M. A review of drug-induced oral reactions. J Contemp Dent Pract. 2003;1:10-31.
13. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-1608.
14. Tomita H, Yoshikawa T. Drug-related taste disturbances. Acta Otolaryngol Suppl. 2002;546:116-121.
15. Taybos G. Oral changes associated with Tobacco use. Am J Med Sci. 2003;326:179-182. (Pubitemid 37271389)
16. Abid S, Mumtaz K, Jafri W, et al. Pill-induced esophageal injury: endoscopic features and clinical outcomes. Endoscopy. 2005;37:740-744. (Pubitemid 41078907)
17. Bott S, Prakash C, McCallum RW. Medication-induced esophageal injury: survey of the literature. Am J Gastroenterol. 1987;82:758-763. (Pubitemid 17145104)
18. Carlborg B, Densert O. Esophageal lesions caused by orally administered drugs. An experimental study in the cat. Eur Surg Res. 1980;12:270-282.
19. O'Neill J, Remington T. Drug-induced esophageal injuries and dysphagia. The Ann Pharmacother. 2003;37:1675-1684.
20. Castell DO, Murray JA, Tutuian R, et al. Review article: the pathophysiology of gastro-oesophageal reflux disease oesophageal manifestations. Aliment Pharmacol Ther. 2004; 20(suppl):14-25. (Pubitemid 39657651)
21. Richter JE. Gastroesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2007;21:609-631.
22. Shaker R. Gastroesophageal reflux disease: beyond mucosal injury. J Clin Gastroenterol. 2007;41:S160-S162. (Pubitemid 46956127)
23. Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract: the doubleedged sword. Arthritis Rheum. 1995;38:5-18.
24. Schoen RT, Vender RJ. Mechanisms of nonsteroidal antiinflammatory drug-induced gastric damage. Am J Med. 1989; 86:449-458. (Pubitemid 19103913)
25. Dominick KL, Ahern FM, Gold CH, et al. Gender differences in NSAID use among older adults with osteoarthritis. Ann Pharmacother. 2003;37:1566-1571. (Pubitemid 37315092)
26. Graham DY, Smith JL, Holmes GI, et al. Nonsteroidal antiinflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa. Clin Pharmacol Ther. 1985;38:65-70.
27. Rodríguez LAG, Cattaruzzi C, Troncon MG, et al. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med. 1998;158:33-39. (Pubitemid 28070443)
28. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114:257-263.
29. Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992;327:749-754.
30. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammtory drugs. N Engl J Med. 1999;340:1888-1899. (Pubitemid 29272670)
31. Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature. Arch Intern Med. 1992;152: 625-632.
32. Graham DY, Openkun AR, Willingham FF, et al. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3:55-59.
33. Reuter BK, Davies NM, Wallace JL. Nonsteroidal antiinflammatory drug enteropathy in rats: role of permeability, bacteria and enterohepatic circulation. Gastroenterology. 1997; 112:109-117.
34. Somasundaram S, Sigthorsson G, Simson RJ, et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther. 2000;14:639-650. (Pubitemid 30240758)
35. Bjarnason I, Williams P, So A, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of nonsteroidal anti-inflammatory drugs. Lancet. 1984;24:1171-1174. (Pubitemid 15217670)
36. Bjarnason I, Zanaelli G, Prouse P, et al. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet. 1987;2:711-714. (Pubitemid 17125695)
37. Bjarnason I, Zanelli G, Smith T, et al. Nonsteroidal antiin- flammatory drug-induced intestinal inflammation in humans. Gastroenterology. 1987;93:480-489. (Pubitemid 17119242)
38. Morris AJ, Wasson LA, Mackenzie JF. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut. 1992;33: 887-889.
39. Kepczyk T, Kadakia SC. Prospective evaluation of gastrointestinal tract in patients with iron-deficiency anemia. Dig Dis Sci. 1995;40:1283-1289.
40. Li F, Gurudu S, De Petris G, et al. Retention of the capsule endoscope: a single experience of 1000 capsule endoscopy procedures. Gastrointest Endosc. 2008;68:174-180.
41. Pusztaszeri MP, Genta RM, Cryler BL. Drug-induced injury in the gastrointestinal tract: clinical and pathologic considerations. Nat Clin Pract Gastroenterol Hepatol. 2007;4:442-453.
42. Blinder GH, Hautekeete ML, Holvoet JP, et al. Duodenal diaphragm like stricture induced by acetylsalicylic acid. Dig Dis Sci. 2005;39:0163-2116.
43. Ingoldby CJ. Perforated jejunal diverticulum due to local iron toxicity. Br Med J. 1977;1:949-950.
44. Saltzman JR, Kowdley KV, Pedrosa MC, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology. 1994;106:615-623.
45. Serfaty-Lacrosniere C, Wood RJ, Voytko D, et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr. 1995;14: 364-368.
46. Koop H, Bachem MG. Serum iron, ferritin and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol. 1992;14:288-292.
47. Riddell RH. The gastrointestinal tract. In: Riddel RH, ed. Pathology of Drug-induced and Toxic Disease. New York: Churchill Livingstone; 1982:515-605.
48. Stamm C, Burkhalter CE, Pearce W, et al. Benign colonic ulcers associated with nonsteroidal anti-inflammatory drug ingestion. Am J Gastroenterol. 1994;89:2230-2233. (Pubitemid 24363676)
49. Halter F, Weber B, Huber T, et al. Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. J Clin Gastroenterol. 1993;16:74-80. (Pubitemid 23021405)
50. Bridges AJ, Marshall JB, Diaz-Arias AA. Acute eosinophilic colitis and hypersensitivity reaction associated with naproxen therapy. Am J Med. 1990;89:526-527.
51. Hall RI, Petty AH, Cobden I, et al. Enteritis and colitis associated with mefenamic acid. Br Med J. 1983;287:1182.
52. Hass D, Kozuch P, Brandt L. Pharmacologically Mediated colon ischemia. Am J Gastroenterol. 2007;102:1765-1780.
53. Brand LJ, Boley SJ. Colonic ischemia. Surg Clin North Am. 1992;72:203-229.
54. Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004;99:1175-1190.
55. Frudenberger RS, Cappell MS, Hutt DA. Intestinal infarction after intravenous cocaine administration. Ann Intern Med. 1990;113:715-716.
56. Linder JD, Monkemuller KE, Raijman I, et al. Cocaineassociated ischemic colitis. South Med J. 2000;93:909-913.
57. Stillman AE, Weinberg M, Mast WC, et al. Ischemic bowel disease attributable to ergot. Gastroenterology. 1977;72:1336-1337. (Pubitemid 8116711)
58. McClennan BL. Ischemic colitis secondary to Premarin: report of a case. Dis Colon Rectum. 1976;19:618-620.
59. Friedel D, Thomas R, Fisher RS. Ischemic colitis during treatment with alosetron. Gastroenterology. 2001;120:557-560.
60. Beyer KL, Bickel JT, Butt JH. Ischemic colitis associated with dextroamphetamine use. J Clin Gastroenterol. 1991;13: 198-201.
61. Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol. 1997;21:60-69. (Pubitemid 27026606)
62. Dial S, Delaney C, Scheneider V, et al. Proton pump inhibitor use and risk of community-acquired Clostridium difficileassociated disease defined by prescription for oral Vancomycin therapy. CMAJ. 2006;175:745-748. (Pubitemid 44520987)
63. Al-Tureihi FI, Hassoun A, Wolf-Klein G, et al. Albumin, length of stay and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients. J Am Med Dir Assoc. 2005;6:105-108. (Pubitemid 40353089)
64. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile- associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273-281. (Pubitemid 40445086)
65. Hogenauer C, Cord L, Eckhard B, et al. Klebsiella oxytoca as a causative organism of Antibiotic-associated Hemorrhagic Colitis. N Engl J Med. 2006;355:2418-2426. (Pubitemid 44903746)
66. Philbrick AM, Ernst ME. Amoxicillin-associated hemorrhagic colitis in the presence of Klebsiella oxytoca. Pharmacotherapy. 2007;27:1603-1607. (Pubitemid 350060214)
67. Kronawitter U, Kemeny NE, Blumgart L. Neutropenic enterocolitis in a patient with colorectal carcinoma: unusual course after treatment with 5-fluoruracil and leucovirin-a case report. Cancer. 1997;15:656-660. (Pubitemid 27339819)
68. Petruzzelli GJ, Johnson JT, de Vries EJ. Neutropenic enterocolitis. A new complication of head and neck cancer chemotherapy. Arch Otolaryngol Head Neck Surg. 1990;116: 209-211.
69. Trescot AM, Boswell MV, Atluri SL, et al. Opioid guideline in the management of chronic non-cancer pain. Pain Physician. 2006;9:1-39.
70. Grunkemeier D, Cassara J, Dalton C, et al. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterology Hepatol. 2007;5:1126-1139. (Pubitemid 47488969)
71. Ghadially FN, Walley VM. Melanoses of the gastrointestinal tract. Histopathology. 1994;25:197-207.
72. Dharmarajan TS, Kumar A, Pitchumoni CS. Drug-Nutrient interactions in older adults. Pract Gastroenterol. 2002;36: 37-55.
73. Eckardt VF, Kanzler G, Remmele W. Anorectal ergotism: another cause of solitary rectal ulcers. Gastroenterology. 1986; 91:1123-1127. (Pubitemid 16007213)
74. Gizzi G, Villani V, Brandi G, et al. Ano-rectal lesions in patients taking suppositories containing non-steroidal antiinflammatory drugs (NSAID). Endoscopy. 1990;22:146-148. (Pubitemid 20199837)
75. de Parades V, Sultan S, Bauer P. Ano-rectal and colonic complications of suppositories and enemas. Gastroenterol Clin Biol. 1996;20:446-452. (Pubitemid 26244638)
76. Lankisch PG, Droege M, Gottesleben F. Drug-induced acute pancreatitis: incidence and severity. Gut. 1995;37:565.
77. Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5:648-661. (Pubitemid 46830046)
78. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39:709-716.